Premium
Novel transgenic technology reveals several molecular adaptations and potential therapeutic targets in the direct pathway in levodopa‐induced dyskinesia
Author(s) -
Visanji Naomi P.
Publication year - 2014
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.25906
Subject(s) - dyskinesia , levodopa , movement disorders , neuroscience , psychology , disease , parkinson's disease , medicine